William Arsani
Insider CIK 1848372 · DSGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics, Inc. | S Sale | 2025-08-13 | 2025-08-14 | 345,000 | $5.25 | $1.81M | 2,655,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2025-08-13 | 2025-08-14 | 217,627 | $5.25 | $1.14M | 1,000,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2024-08-09 | 2024-08-12 | 814,874 | $4.25 | $3.46M | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 19,000 | — | $0 | 19,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2023-08-29 | 2023-08-30 | 1,960,000 | $2.44 | $4.78M | 3,000,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2023-08-28 | 2023-08-30 | 275,000 | $2.15 | $591.3K | 1,040,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2022-03-21 | 2022-03-22 | 25,000 | $18.99 | $474.7K | 2,797,501 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2021-08-31 | 2021-09-02 | 40,000 | $15.45 | $618.0K | 2,772,501 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2021-03-30 | 2023-09-06 | 700,000 | $20.00 | $14.00M | 700,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2023-09-06 | 814,874 | — | $0 | 814,874 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2023-09-06 | 1,217,627 | — | $0 | 1,217,627 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 1,328,245 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 1,984,733 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 814,874 | — | $0 | 2,032,501 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 700,000 | $20.00 | $14.00M | 2,732,501 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,217,627 | — | $0 | 1,217,627 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2021-03-25 | 2021-03-29 | 15,000 | — | $0 | 15,000 | SEC↗ |